MCUJF.US Medicure Inc

Healthcare Biotechnology USA Stocks
2.89 USD
Close of Nov 15, 2026
0.6700 3.45
Market cap
USD 30.1M
P/E
-
P/B
3.46x
ROE
-31.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is MCUJF.US undervalued?

Graham number

The Graham number of Medicure Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Medicure Inc fundamental analysis

No fundamental analysis for Medicure Inc yet.

Medicure Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Medicure Inc

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-…

Full company profile